Barbarino Sheila C
Barbarino Surgical Arts, Austin, TX, USA.
J Cosmet Dermatol. 2021 Jan;20(1):62-66. doi: 10.1111/jocd.13505. Epub 2020 Jul 27.
Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction.
To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)).
PATIENTS/METHODS: Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire.
The study enrolled 10 subjects aged 32-68 years old. Physician GAIS scores of subject appearance at 1 month were rated as "very much improved" in 80% and "much improved" in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed.
Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well-tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction.
颞部凹陷是衰老的早期迹象，常被忽视，但矫正后可显著提高患者和医生的满意度。
评估医生和患者对颞部凹陷对外貌影响的认知，并评估注射含利多卡因的羟基磷灰石（CaHA(+)）后的治疗满意度。
患者/方法：招募颞部凹陷程度在有效颞部凹陷量表上≥2级的患者。采用推注技术在骨膜上注射CaHA(+)。在治疗前和治疗后30天拍照，由三名评估医生使用全球美学改善量表（GAIS）和颞部凹陷量表进行评分。同一名医生评估患者治疗前后的年龄。患者对照片进行评分，作为满意度问卷的一部分。
该研究纳入了10名年龄在32 - 68岁的患者。1个月时医生对患者外貌的GAIS评分中，80%的患者被评为“改善非常明显”，20%的患者被评为“改善明显”。90%的患者治疗后颞部凹陷评分为1级。在对患者真实年龄进行盲法评估后，患者感知年龄的估计值平均比实际年龄小4岁。大多数患者在治疗前未意识到颞部凹陷，但10名患者中有9名对结果非常满意至极其满意，且所有患者都愿意再次接受治疗。未观察到治疗并发症。
颞部治疗可产生显著的美学效果，在面部年轻化治疗中不应被忽视。CaHA(+)是一种用于颞部的有效且耐受性良好的产品，患者和医生的满意度很高。
